United States · FDA National Drug Code directory
loteprednol etabonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70748-300_822adc09-88c3-41fa-922a-66dfa7e412b2
- Product NDC
- 70748-300
- Form
- SUSPENSION
- Composition / generic term
- loteprednol etabonate
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250715
- Source listing expiry
- 20271231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (70748-300-01) / 5 mL in 1 BOTTLE · 70748-300-01
- 1 BOTTLE in 1 CARTON (70748-300-02) / 10 mL in 1 BOTTLE · 70748-300-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →